
HLS Therapeutics
Provides access to treatments critical to patients and their caregivers with the brand names they trust.
Market cap
$111m
Enterprise value
$157m
Share price
CAD4.80 HLS.TO
Authorizing premium user...
Provides access to treatments critical to patients and their caregivers with the brand names they trust.